Clinical Research Directory
Browse clinical research sites, groups, and studies.
Statin Therapy in Patients With Early Stage ADPKD
Sponsor: University of Colorado, Denver
Summary
This study plans to learn if pravastatin is helpful in slowing down the progression of kidney disease in adults with autosomal dominant polycystic kidney disease (ADPKD). Pravastatin has been approved by the Food and Drug Administration (FDA) for adults for treatment of hyperlipidemia (high cholesterol levels). The investigators are using pravastatin in this study as an investigational drug for treatment of ADPKD.
Key Details
Gender
All
Age Range
25 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2017-08-31
Completion Date
2025-09-30
Last Updated
2025-05-08
Healthy Volunteers
No
Interventions
Pravastatin
Anti-inflammatory, anti-oxidative stress, and anti-proliferative therapy
Placebo
Inactive tablet
Locations (1)
University of Colorado Denver Anschutz Medical Campus
Denver, Colorado, United States